Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MVE Biological Solutions is a commercial-stage life sciences equipment company focused on cryogenic storage and transport systems for biological samples and materials. The business is best known for manufacturing liquid nitrogen-based cryogenic freezers, aluminum dewars, vapor shippers, accessories, and monitoring solutions used in biobanking, biorepositories, cell and gene therapy logistics, IVF and reproductive medicine, research laboratories, and animal health. The company originated as the Chart MVE Biomedical business under Chart Industries and was acquired by Cryoport in 2020. Today it operates as a Cryoport subsidiary and supports the broader temperature-controlled supply chain ecosystem serving biopharma, healthcare, and animal health customers. MVE is not a drug developer; its value lies in enabling storage, handling, and transportation of high-value biological materials with compliance-focused cryogenic equipment and related technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MVE Biological Solutions.